AI Article Synopsis
- The development of new antimicrobial agents for veterinary use faces similar business and technical challenges as those for human medicine.
- Concerns are rising among stakeholders that using certain antimicrobial classes in animals could contribute to increasing antibiotic resistance in humans, especially concerning food-borne illnesses.
- Consequently, there is a growing focus on the connection between veterinary and human antibiotic use, prompting a shift in the development of new antimicrobial agents for the veterinary market.
Article Abstract
The identification and early development of novel antimicrobial agents for use in veterinary medicine is subject to many of the same business and technical challenges as those found in antimicrobial agent use for human infectious disease. However, as awareness that some of the antimicrobial classes used in veterinary medicine are the same as used in human medicine, concern by multiple stakeholders has increased that this nonhuman use might be contributing to the problem of antimicrobial resistance to pathogens in humans, particularly with regard to food-borne diseases, such as salmonellosis and campylobacteriosis. Consequently, the interface between veterinary and human antibiotic use and resistance, especially with respect to human microbial food safety, has begun to redirect the industry pipeline of novel antimicrobial agents to be commercialized for use in veterinary medicine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1749-6632.2010.05788.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!